Cargando…
Binding of Translationally Controlled Tumour Protein to the N-Terminal Domain of HDM2 Is Inhibited by Nutlin-3
Translationally Controlled Tumour Protein (TCTP), a highly conserved protein present in all eukaryotic organisms, has a number of intracellular and extracellular functions including an anti-apoptotic role. TCTP was recently shown to interact with both p53 and HDM2, inhibiting auto-ubiquitination of...
Autores principales: | Funston, Garth, Goh, Walter, Wei, Siau Jia, Tng, Quah Soo, Brown, Christopher, Jiah Tong, Loh, Verma, Chandra, Lane, David, Ghadessy, Farid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418249/ https://www.ncbi.nlm.nih.gov/pubmed/22912717 http://dx.doi.org/10.1371/journal.pone.0042642 |
Ejemplares similares
-
In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition
por: Wei, Siau Jia, et al.
Publicado: (2013) -
Inhibition of Nutlin-Resistant HDM2 Mutants by Stapled Peptides
por: Wei, Siau Jia, et al.
Publicado: (2013) -
Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2
por: Chee, Sharon Min Qi, et al.
Publicado: (2014) -
Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides
por: Wei, Siau Jia, et al.
Publicado: (2016) -
Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket
por: Pradhan, Mohan R, et al.
Publicado: (2019)